|
Volumn 39, Issue 9, 2001, Pages 919-922
|
Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice
|
Author keywords
Acute subacute toxicity; Gallic acid; Mice; NOAEL
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
CHOLESTEROL;
GALLIC ACID;
PROTEIN;
UREA;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG SCREENING;
FEMALE;
HEMATOLOGICAL PARAMETERS;
MALE;
MAXIMUM ALLOWABLE CONCENTRATION;
MORTALITY;
MOUSE;
NONHUMAN;
SERUM;
ACUTE TOXICITY TESTS;
ADMINISTRATION, ORAL;
ANIMALS;
BODY WEIGHT;
FEMALE;
GALLIC ACID;
MALE;
MICE;
NO-OBSERVED-ADVERSE-EFFECT LEVEL;
ORGAN SIZE;
RANDOM ALLOCATION;
TANNINS;
|
EID: 0034909049
PISSN: 02786915
EISSN: None
Source Type: Journal
DOI: 10.1016/S0278-6915(01)00022-9 Document Type: Article |
Times cited : (95)
|
References (18)
|